ArticleFrontiers in oncology2026

TACE-HAIC plus TKIs with/without PD-1 inhibitors for unresectable hepatocellular carcinoma: a propensity score matching study.

Xiadi Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.